Ricks to Succeed Lechleiter at Lilly
![Ricks to Succeed Lechleiter at Lilly](https://www.insideindianabusiness.com/wp-content/uploads/2021/09/11090519_G.jpg)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowAfter 37 years, eight as chief executive officer, John Lechleiter has announced plans to retire from Indianapolis-based Eli Lilly and Co. at the end of the year. The pharmaceutical maker says Senior Vice President Dave Ricks (pictured) will take the helm January 1 and become board chair June 1. Lechleiter, who currently leads the company and the board, will serve as non-executive chairman of the board through May 31. Lechleiter calls it a "logical time" to make the change, as the company continues to navigate a new era that follows a string of patent expirations. Ricks’ successor as president of Lilly Bio-Medicines, a position he has held since 2012, will be announced at a later date.